Covalon announces retirement of board member
Dr. Myrna Francis is retiring as a Covalon board member due to new professional commitments.
MISSISSAUGA — Covalon Technologies Ltd., an advanced medical technologies company, announces that Dr. Myrna Francis is retiring as a member of the Board of Directors of the Company, effective September 24th, 2021, due to new professional commitments that will prevent her from continuing to commit time to Covalon.
Amir Boloor, Chair of Covalon’s Board of Directors, said, “Myrna’s contributions to Covalon have been significant and meaningful. Her extensive healthcare knowledge has helped guide our growing medical products business and our expanding global footprint. We have valued Myrna’s insights in shaping and building Covalon’s leadership team. I am thankful for Myrna’s service to Covalon and wish her all the best.”
“Covalon has been very fortunate to have Myrna serve on our board for the past three years,” stated Brian Pedlar, Covalon’s President and Chief Executive Officer. “She has been a highly effective director and I have always appreciated her wise counsel. We extend our gratitude and best wishes to Myrna in her future endeavors.”
Covalon Technologies Ltd. is a researcher, developer, manufacturer, and marketer of patent-protected medical products that improve patient outcomes in the areas of advanced wound care, infection management and surgical procedures.